Continuous Infusion Apomorphine Approved
On February 4, 2024, the United States Food and Drug Administration approved ONAPGO, a formulation of apomorphine designed for continuous infusion under the skin. ONAPGO was developed …
Four Strategies for Modifying Your Parkinson’s Treatment Plan
When you first begin taking Parkinson’s medications, you may find that they work so well that you rarely or never experience troublesome symptoms. As time passes, however, …
![[Webinar Recording] October 2024 Living With Parkinson’s Meetup: Exenatide, Infusion Levodopa, and Advice](https://www.shufflernews.com/wp-content/uploads/2024/08/EVC-6th-300px.png)
[Webinar Recording] October 2024 Living With Parkinson’s Meetup: Exenatide, Infusion Levodopa, and Advice
The October Living with Parkinson’s Webinar Meetup focuses on discussion of two news items: an update about the phase 3 trial of exenatide and the United States …
First Continuous Infusion Levodopa System Approved in the United States: What You Need to Know About VYALEV
Today, the United States Food and Drug Administration approved the first continuous infusion carbidopa/levodopa system. The treatment, developed by Abbvie and called VYALEV, has been approved for …
The ATLANTIS Study: Seeking Better Dopamine Utilization
Every prescription drug used to treat Parkinson’s (or any other condition) in the US has been tested in clinical trials prior to gaining approval by the …